MX394257B - Vacuna contra coccidiosis. - Google Patents

Vacuna contra coccidiosis.

Info

Publication number
MX394257B
MX394257B MX2018008091A MX2018008091A MX394257B MX 394257 B MX394257 B MX 394257B MX 2018008091 A MX2018008091 A MX 2018008091A MX 2018008091 A MX2018008091 A MX 2018008091A MX 394257 B MX394257 B MX 394257B
Authority
MX
Mexico
Prior art keywords
vaccine
inclusion
coccidiosis
composition
xanthan gum
Prior art date
Application number
MX2018008091A
Other languages
English (en)
Other versions
MX2018008091A (es
Inventor
Colin Crouch
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2018008091A publication Critical patent/MX2018008091A/es
Publication of MX394257B publication Critical patent/MX394257B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/012Coccidia antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención está relacionada a una vacuna mejorada contra Coccidiosis en aves de corral; la vacuna comprende ooquistes de Eimeria vivos en una composición con una viscosidad relativamente alta debido a la inclusión de entre 0.3 y 1.5% p/v de goma xantana; después de la vacunación por aspersión, la nueva vacuna forma perlas que son rápidamente ingeridas por las aves y las cuales proporcionan una toma de vacuna rápida, resultando en una mejora rápida y efectiva de los signos de Coccidiosis después de la infección por reto; la invención también está relacionada a un método para la esterilización por calor de una composición que comprende goma xantana; mediante la inclusión de una concentración de una sal metálica, se puede prevenir una irreversible y dramática reducción en la viscosidad en gran medida.
MX2018008091A 2015-12-29 2016-12-23 Vacuna contra coccidiosis. MX394257B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15203012 2015-12-29
PCT/EP2016/082530 WO2017114775A1 (en) 2015-12-29 2016-12-23 Coccidiosis vaccine

Publications (2)

Publication Number Publication Date
MX2018008091A MX2018008091A (es) 2018-08-23
MX394257B true MX394257B (es) 2025-03-24

Family

ID=55085492

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018008091A MX394257B (es) 2015-12-29 2016-12-23 Vacuna contra coccidiosis.

Country Status (8)

Country Link
US (2) US20190000950A1 (es)
EP (1) EP3397278A1 (es)
JP (1) JP6955497B2 (es)
CN (1) CN108472351A (es)
BR (1) BR112018013082A2 (es)
MX (1) MX394257B (es)
RU (1) RU2767913C2 (es)
WO (1) WO2017114775A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111330001B (zh) * 2020-03-24 2022-05-20 中国农业大学 一种兔球虫病减毒活疫苗助悬剂及悬浮液
JP2023532029A (ja) * 2020-06-26 2023-07-26 ジボ バイオサイエンス,インコーポレイティド コクシジウム症の予防と治療に対する、動物飼料によるプラスの潜在的効果
CN113521264A (zh) * 2021-07-14 2021-10-22 中国农业科学院北京畜牧兽医研究所 一种鸽球虫病活疫苗及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3020226B2 (ja) * 1986-08-18 2000-03-15 ブリティッシュ・テクノロジー・グループ・リミテッド ワクチン
KR100613969B1 (ko) * 1998-12-17 2006-08-18 가부시키가이샤 시세이도 화장료 조성물
AU2002225894A1 (en) * 2000-11-08 2002-05-21 Novus International Inc Methods and compositions for the control of coccidiosis
DE60221227T2 (de) * 2002-04-30 2008-01-31 Sifi S.P.A., Lavinaio-Aci Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen
RU2324498C2 (ru) * 2002-12-09 2008-05-20 Юниверсити Оф Джорджия Рисерч Фаундейшн, Инк. Кокцидиальная вакцина и методы ее приготовления и использования
US7354593B2 (en) 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
US7879342B2 (en) * 2004-03-12 2011-02-01 Univ. Of Georgia Research Foundation, Inc. Vaccine adjuvant and making and using the same
CA2738682A1 (en) * 2004-04-15 2005-10-15 Eng-Hong Lee Soft gel delivery system for treating poultry
ITMI20041255A1 (it) 2004-06-22 2004-09-22 Univ Degli Studi Milano Sistemi microparticellari per somministrazione orale di sostanze biologicamente attive
CN101184500A (zh) * 2005-04-15 2008-05-21 梅瑞尔有限公司 球虫疫苗及其制备和使用方法
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
CA2769223C (en) 2009-07-28 2015-03-17 Vetech Laboratories Inc. Sticky soft gel for treating poultry
CN102727900B (zh) * 2012-07-05 2014-05-07 烟台青大生物制药有限公司 一种鸡球虫病疫苗助悬剂及悬浮液

Also Published As

Publication number Publication date
RU2018127638A3 (es) 2020-01-30
EP3397278A1 (en) 2018-11-07
US11413343B2 (en) 2022-08-16
JP2019504044A (ja) 2019-02-14
RU2767913C2 (ru) 2022-03-22
CN108472351A (zh) 2018-08-31
WO2017114775A1 (en) 2017-07-06
JP6955497B2 (ja) 2021-10-27
US20200323971A1 (en) 2020-10-15
MX2018008091A (es) 2018-08-23
BR112018013082A2 (pt) 2018-12-11
RU2018127638A (ru) 2020-01-30
US20190000950A1 (en) 2019-01-03

Similar Documents

Publication Publication Date Title
PH12018500856A1 (en) Respiratory syncytial virus vaccine
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
MX2018004916A (es) Vacuna contra el virus de la influenza de amplio espectro.
MX389228B (es) Composiciones para tratar el cabello.
NZ704584A (en) Liquid stable virus vaccines
BR112019025388A2 (pt) Suplemento de ração animal, composição de ração animal, usos de um suplemento de ração animal, métodos para produzir um suplemento de ração animal e para produzir uma composição de ração animal
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
MX390860B (es) Composiciones adyuvantes y metodos relacionados.
PH12016502003A1 (en) Novel bacteriophage and composition containing same
EA201591365A1 (ru) Способ обработки волос
PH12016501999A1 (en) Novel bacteriophage and composition containing same
BR112016028316A2 (pt) composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento
PH12016502001A1 (en) Novel bacteriophage and composition comprising same
MX381252B (es) Virus de la enteritis del pato y usos del mismo.
BR112017006779A2 (pt) composição farmacêutica oral de baixa dose seu processo de preparação e método de tratamento
MX394257B (es) Vacuna contra coccidiosis.
GB2571850A (en) Maca compositions and methods of use
CL2017000118A1 (es) Métodos y composiciones para tratar desórdenes relacionados con el vih
HUE048849T2 (hu) Corynebacterium nemzetségbe tartozó mikroorganizmus L-aminosav elõállítására és eljárás L-aminosav elõállítására annak alkalmazásával
BR112017001963A2 (pt) composição farmacêutica oral, seu processo de preparação e método de tratamento
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
EA201890419A1 (ru) ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ
PH12016502000A1 (en) Novel bacteriophage and composition comprising same
EA201992844A1 (ru) Новые пероральные составы на основе белиностата
AR106090A1 (es) Métodos y formulaciones para reducir las emisiones de bovino